In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
Key research from the conference highlights opioid addiction research.
Listen to our latest NCTalks podcast with leading neurosurgeon, Ali Rezai, to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade.
Participants receiving the antibody treatment were also able to take less additional migraine medication compared with those in the placebo group.
Research presented at the Congress of the European Academy of Neurology 2017 confirms that cannabinoids are as suitable for preventing migraine attacks as other pharmaceutical treatments.
This review explores the limitations of the present technology and current challenges of SCS before reviewing some of the most important recent advances.
A large-scale, population-based study has demonstrated a relationship between persistent pain and cognitive decline.
The new retrospective population-based cohort study from the Mayo Clinic included data from 1993 patients with polyneuropathy.
Dr Deer discusses his career highlights, most memorable patient cases, and looks ahead at future challenges and trends in the field of neuromodulation.